The Multidisciplinary Approach to Treating Prostate Cancer Using Radiopharmaceuticals

 

E David Crawford

The Androgen Axis Is Not the Only Driver of Advanced Prostate Cancer Disease Progression

E. David Crawford, MD
University of Colorado, Denver
Aurora, CO

VIEW PRESENTATION

 

 

Neal D. Shore

Radiopharmaceuticals: Has There Been Progress?

Neal D. Shore, MD, FACS
Atlantic Urology Clinics, LLC
Myrtle Beach, SC

VIEW PRESENTATION

 

 

Daniel Petrylak

Update on Clinical Trials and New Targets

Daniel P. Petrylak, MD
Yale Cancer Center
New Haven, CT

VIEW PRESENTATION

 

 

Phillip J Koo

Osseous Metastatic Disease and Radium 223: Lessons Learned and Future Directions

Phillip J. Koo, MD
Banner MD Anderson Cancer Center
Gilbert, AZ

VIEW PRESENTATION

 

 

Daniel PetrylakDaniel P. Petrylak, MD
Yale Cancer Center
New Haven, CT

VIEW PRESENTATION

 

 

 

Grand Rounds in Urology

Discussion

E. David Crawford, MD
University of Colorado, Denver
Aurora, CO